Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, and Allegheny Health Network, an academic healthcare system serving the diverse greater western Pennsylvania community that provides pioneering medical research and education programs focused on transforming healthcare, today announced the initiation of a Phase 1/2 study to assess the safety and efficacy of azeliragon in patients refractory to first-line treatment of metastatic pancreatic cancer.
/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other.
Leaders of prominent cancer centers in the U.S. say a growing shortage is forcing doctors to switch medications and delaying some care. It's a problem that is leaving local doctors and patients concerned.
While Pennsylvania’s largest medical system appears to be feeling the most immediate consequences of supply chain disruptions, Allegheny Health Network and other regional and national cancer centers will likely face difficult choices in the coming weeks and months.